AMERGE (nda020763)- (EQ 2.5MG BASE,EQ 1MG BASE)

Generic Name	NARATRIPTAN HYDROCHLORIDE	Innovator	GLAXOSMITHKLINE LLC
Dosage	EQ 2.5MG BASE,EQ 1MG BASE
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2010-Jul-07	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	AMERGE is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
5	0	3

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 2.5MG BASE	**	**	-	-	3
EQ 1MG BASE	**	**	-	2	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	3

Manufacturing Details of AMERGE